MetaCap

Apollomics Statistics

NASDAQ: APLMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.54-1.16 (-6.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Apollomics by the numbers

Apollomics has a market capitalization of $45.3 million based on 2.91M shares outstanding. With trailing EPS of $-0.25, Apollomics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.0% below its 50-day average and 17.6% below its 200-day average.

Average daily trading volume is 11.07K shares, or about $171,988 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

APLM valuation vs. peer median

APLM compared with the median of 8 peer companies
MetricAPLMPeer medianDifference
Market cap$45.28M$45.73M-1%
Avg. volume11.07K827.29K-99%

Peer median across 8 companies: RNXT, QUCY, HOWL, GANX, MIST, TNXP, ANVS, VRCA.

Valuation

Price and trading

Previous close
16.69
Open
16.00
Day range
15.54 – 16.51
52-week range
12.58 – 28.29
52-week change
+7.43%
Beta
—
Volume
4.07K

Dividends and events

Additional statistics

Market Cap
45.28M
Forward Pe
-23.90
Eps
-0.25
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
28.29
Week52 Low
12.58
Avg Volume
11,071.00
Shares Outstanding
2.91M
Ma50
20.99
Ma200
18.85
Pct From52w High
-45.09%
Pct From52w Low
23.49%

Related